ASTRAZENECA CONFIRMS DELAY OF VACCINE SUPPLY TO EU
British-Swedish pharmaceutical firm AstraZeneca on Friday partially confirmed reports of a temporary delay to its COVID-19 vaccine deliveries to the European Union (EU), Deutsche Presse-Agentur (dpa) reported.
The Financial Times reported on Friday that there would be a cut in deliveries this week. AstraZeneca confirmed there would be delays this week, but the confirmed volume of deliveries was not at issue, according to a statement released on Friday evening.
"We communicated to the [European Commission] and member states last week that one of the two batches for delivery this week would require testing and will be delivered soon," according to the statement.
AstraZeneca said that "small fluctuations" in weekly deliveries depending on the distribution of quality and safety testing were typical, but the firm was on track to meet its delivery plans of 70 million doses to the EU in the second quarter.
An EU spokesperson declined to comment on the deliveries. "We do not comment on the state of deliveries. But we remain in contact with the company to ensure timely delivery of a sufficient number of doses," the spokesperson said.
"In this context, we have also launched a dispute resolution with the company on the basis of which we hope to reach an agreement on the outstanding issues," the spokesperson added.